At the time of writing, AMGEN Inc. [AMGN] stock is trading at $322.73, down -0.22%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AMGN shares have gain 3.27% over the last week, with a monthly amount drifted -3.12%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
AMGEN Inc. [NASDAQ: AMGN] stock has seen the most recent analyst activity on August 07, 2024, when Wells Fargo downgraded its rating to a Equal Weight and also boosted its price target to $335 from $320. Previously, William Blair upgraded its rating to Outperform on May 03, 2024. On May 03, 2024, upgrade upgraded it’s rating to Equal Weight and revised its price target to $300 on the stock. Leerink Partners downgraded its rating to a Market Perform and reduced its price target to $318 on February 07, 2024. Daiwa Securities upgraded its rating to Buy for this stock on December 21, 2023, and upped its price target to $320. In a note dated December 19, 2023, BMO Capital Markets upgraded an Outperform rating on this stock and boosted its target price from $286 to $326.
For the past year, the stock price of AMGEN Inc. fluctuated between $248.38 and $346.85. Currently, Wall Street analysts expect the stock to reach $286.95 within the next 12 months. AMGEN Inc. [NASDAQ: AMGN] shares were valued at $322.73 at the most recent close of the market. An investor can expect a potential drop of -11.09% based on the average AMGN price forecast.
Analyzing the AMGN fundamentals
According to AMGEN Inc. [NASDAQ:AMGN], the company’s sales were 30.74B for trailing twelve months, which represents an 19.90% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.2%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.5 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of10.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 320.07 points at the first support level, and at 317.42 for the second support level. However, for the 1st resistance point, the stock is sitting at 324.87, and for the 2nd resistance point, it is at 327.02.
Ratios To Look Out For
It is important to note that AMGEN Inc. [NASDAQ:AMGN] has a current ratio of 1.26. In addition, the Quick Ratio stands at 0.89 and the Cash Ratio stands at 0.43. Considering the valuation of this stock, the price to sales ratio is 5.64, the price to book ratio is 29.26 and price to earnings (TTM) ratio is 55.60.
Transactions by insiders
Recent insider trading involved Grygiel Nancy A., SVP & CCO, that happened on May 03 ’24 when 2117.0 shares were sold. SVP & CCO, Grygiel Nancy A. completed a deal on Dec 04 ’23 to sell 2096.0 shares. Meanwhile, EVP, Gen. Counsel & Secy. Graham Jonathan P sold 10000.0 shares on Nov 08 ’23.
